Carole Elodie Aubert

Has grant

University of Bern
Country flagSwitzerland

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Not to D: comparison of two interventions to reduce inappropriate measurement and supplementation of vitamin D

Open Date: 2022-05-01

Close Date:

Grant: Close

Impacts of an INtervention TO increase MOBility in older hospitalised medical patients (INTOMOB): a cluster randomised controlled trial

Open Date: 2022-02-01

Close Date: 2026-01-01

Grant: Close

Deintensification of antihypertensive treatment in the elderly: Estimating the effect on the risk of fall injuries, syncope and cardiovascular events

Open Date: 2019-09-01

Close Date: 2021-02-01

Grant: Close

Patterns of multimorbidity and their association with healthcare resource utilization: a multinational study

Open Date: 2017-06-01

Close Date: 2019-06-01

Grant: Close

Patterns of multimorbidity and their association with healthcare resource utilization: a multinational study

Open Date: 2017-05-01

Close Date:

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Background: There is little evidence for statins for primary cardiovascular prevention in older adults. Consequently, it is important to assess patient attitudes toward the use of statins, which might differ from attitudes toward other medications. We aimed to describe older patient attitudes toward deprescribing statins versus general medications. Methods: We conducted a survey using the revised Patients’ Attitudes Toward Deprescribing questionnaire in its original version and adapted to statin use in adults ≥65 years taking a statin for primary prevention. Results: Among the 47 participants (mean age 74.6 years), 42 (89%) were satisfied with their current therapy, but still willing to stop ≥1 of their medications upon their doctor’s advice. About 68% ( N = 32) were satisfied with their statin therapy, while 83% ( N = 39) would accept to consider deprescribing. Twenty-six (55%) participants were concerned about missing future benefits when stopping their general medications and 17 (36%) when stopping their statin. Eight (17%) participants believed they were experiencing side effects of statins and twice as many for general medication (38%, N = 18). Conclusion: Our study provides insight about differences and similarities in patient attitudes toward deprescribing general medications and statins in primary prevention. This information could support patient-centered conversations and shared-decision making about deprescribing.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (2)

Justin Presseau

Associate Professor

University of Ottawa

CANADA
View details

Fabian D. Liechti

University Hospital of Bern

SWITZERLAND
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.